MRNA

Why the Covid-19 vaccine is less common than the flu vaccine

Covid-19 vaccines leave pregnant women for a while

Covid-19 vaccines leave pregnant women for a while

Vaccine expectations are boosted by data from Novavax and J&J, but fears about new variants remain

It was a gloomy morning in the Covid-19 battle. The market is looking at Johnson & Johnson for hope.

J&J could share the results of the phase 3 vaccine study this week

CDC: The modern COVID-19 vaccine can cause allergic reactions in some people

California authorities are verifying the death of the person who received the Covid-19 vaccine earlier

Johnson & Johnson aims for 100 million doses of vaccine by spring. The stock market is based on it.

Studies on the coronavirus strain in South Africa raise concerns about the immune response